High serum levels of a non-(1-84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients

Pediatric Nephrology

Volumn 16, Issue 12, 2001, Pages 1011-1014

  Salomon, R ^a   Charbit, M ^a   Gagnadoux, M F ^a   Niaudet, P ^a   Gao, P ^b   Cantor, T ^b   Souberbielle, J C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Scantibodies Laboratory Inc   (United States)

Author keywords

Haemodialysis; Immunoassay; Ionized calcium; Parathyroid hormone; Renal osteodystrophy

Indexed keywords

ALFACALCIDOL; BICARBONATE; CALCIUM CARBONATE; CALCIUM ION; GROWTH HORMONE; PARATHYROID HORMONE; PARATHYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEMODIALYSIS; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PARATHYROID HORMONE BLOOD LEVEL; PATIENT MONITORING; PEDIATRICS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SHORT STATURE;

ADOLESCENT; BODY HEIGHT; CALCIUM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOASSAY; IONS; MALE; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; REFERENCE VALUES; RENAL DIALYSIS;

EID: 0035661435     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670100014     Document Type: Article

References (16)

1. Intact parathyroid hormone overestimates the presence and severity of parathyroid-related osseous abnormalities in uremia
2. Relationship between intact PTH (1-84) parathyroid hormone and bone histomorphometry parameters in dialysis patients without aluminium toxicity
3. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples
4. A novel mechanism for skeletal resistance in uremia
5. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values
6. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone detected by intact PTH assays
7. Development of a novel immunoradiometric assay exclusively specific for biologically active whole parathyroid hormone (1-84): Implications for improvement of accurate assessment of parathyroid function
8. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implication for PTH measurements in renal failure
9. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia
10. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD
11. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD
12. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
13. Risk factors for vertebral fractures in renal osteodystrophy
14. Optimal range of plasma concentration of true 1-84 parathyroid hormone in patients on maintenance dialysis
15. The peripheral metabolism of parathyroid hormone
16. Parathyroid hormone-immunoradiometric assay as noninvasive predictors of renal osteodystrophy: The need for bone histomorphometric validation